Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Getz Heather C
   2. Issuer Name and Ticker or Trading Symbol
BIOTELEMETRY, INC. [BEAT] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive VP & CFO
(Last)
(First)
(Middle)
1000 CEDAR HOLLOW RD. SUITE 102		 3. Date of Earliest Transaction (Month/Day/Year)
01/25/2019
(Street)

MALVERN, PA 19355		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/25/2019   M   38,524 A $ 2.54 119,085 D  
Common Stock 01/25/2019   M   26,465 A $ 2.8 145,550 D  
Common Stock 01/25/2019   S(1)   64,989 D $ 70.09 (2) 80,561 D  
Common Stock 01/28/2019   M   28,194 A $ 2.8 108,755 D  
Common Stock 01/28/2019   S(1)   28,194 D $ 70 (3) 80,561 D  
Common Stock 01/29/2019   M   200 A $ 2.8 80,761 D  
Common Stock 01/29/2019   S(1)   200 D $ 70 80,561 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 2.54 01/25/2019   M     38,524   (4) 02/19/2023 Common Stock 38,524 $ 0 0 (5) D  
Stock Options (Right to Buy) $ 2.8 01/25/2019   M     26,465   (6) 02/21/2022 Common Stock 26,465 $ 0 38,984 D  
Stock Options (Right to Buy) $ 2.8 01/28/2019   M     28,194   (6) 02/21/2022 Common Stock 28,194 $ 0 10,790 D  
Stock Options (Right to Buy) $ 2.8 01/29/2019   M     200   (6) 02/21/2022 Common Stock 200 $ 70 10,590 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Getz Heather C
1000 CEDAR HOLLOW RD. SUITE 102
MALVERN, PA 19355		       Executive VP & CFO  

Signatures

 /s/ Peter F. Ferola, Attorney-in-Fact   01/29/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.
(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.66, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote 3 to this Form 4.
(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.11, inclusive.
(4) The stock options vested in four equal annual installments, which began on December 31, 2013. The options were fully exercisable as of December 31, 2016.
(5) The reporting person's Form 4 filed on February 21, 2012, reporting this grant of options overreported the options by 748 shares. Therefore, the Form 4 filed on January 23, 2019, overreported 748 shares in Column 9.
(6) The stock options vested in four equal annual installments, which began on December 31, 2012. The options were fully exercisable as of December 31, 2015.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.